Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.45 is in line with its 5-year average of -1.47, around the middle of its 5-year range (-2.39–-1.03).
29.78% above its 12-month average of -2.06.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.25.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
EARNINGS PER SHARE (EPS)
-1.45
EARNINGS PER SHARE (EPS) AVG TTM
-2.06
EARNINGS PER SHARE (EPS) AVG 3Y
-1.65
EARNINGS PER SHARE (EPS) AVG 5Y
-1.47
EARNINGS PER SHARE (EPS) AVG 10Y
-1.60
EARNINGS PER SHARE (EPS) AVG 15Y
-1.78
EARNINGS PER SHARE (EPS) AVG 20Y
-2.14
CURRENT VS TTM AVG
+29.78%
CURRENT VS 3Y AVG
+12.12%
CURRENT VS 5Y AVG
+1.14%
CURRENT VS 10Y AVG
+9.52%
CURRENT VS 15Y AVG
+18.53%
CURRENT VS 20Y AVG
+32.35%
Avita Medical Inc.
Market Cap
$322.13M
Earnings Per Share (EPS)
-1.45
TTM Avg
-2.06
3Y Avg
-1.65
5Y Avg
-1.47
Market Cap
$321.57M
Earnings Per Share (EPS)
-3.72
TTM Avg
-2.75
3Y Avg
-1.76
5Y Avg
-1.48
Market Cap
$322.84M
Earnings Per Share (EPS)
-1.18
TTM Avg
-0.80
3Y Avg
-0.80
5Y Avg
-0.72
Market Cap
$323.66M
Earnings Per Share (EPS)
-1.58
TTM Avg
-1.99
3Y Avg
-1.86
5Y Avg
-1.78
Market Cap
$324.08M
Earnings Per Share (EPS)
-0.63
TTM Avg
-0.48
3Y Avg
-0.42
5Y Avg
-0.42
Market Cap
$315.67M
Earnings Per Share (EPS)
-1.00
TTM Avg
-1.40
3Y Avg
-2.02
5Y Avg
-1.91
Market Cap
$328.98M
Earnings Per Share (EPS)
2.65
TTM Avg
-5.30
3Y Avg
-10.00
5Y Avg
-10.52
Market Cap
$305.56M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.02
3Y Avg
-0.02
5Y Avg
-0.02
Market Cap
$301.12M
Earnings Per Share (EPS)
-0.98
TTM Avg
-1.02
3Y Avg
-4.71
5Y Avg
-10.90
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Avita Medical Inc. (RCEL) | $322.13M | -1.45 | -2.06 | -1.65 | -1.47 |
| Sanara MedTech Inc. (SMTI)vs › | $321.57M | -3.72 | -2.75 | -1.76 | -1.48 |
| ClearPoint Neuro, Inc. (CLPT)vs › | $322.84M | -1.18 | -0.80 | -0.80 | -0.72 |
| Cabaletta Bio, Inc. (CABA)vs › | $323.66M | -1.58 | -1.99 | -1.86 | -1.78 |
| CapsoVision, Inc. (CV)vs › | $324.08M | -0.63 | -0.48 | -0.42 | -0.42 |
| C4 Therapeutics, Inc. (CCCC)vs › | $315.67M | -1.00 | -1.40 | -2.02 | -1.91 |
| Agenus Inc. (AGEN)vs › | $328.98M | 2.65 | -5.30 | -10.00 | -10.52 |
| Mobia Medical, Inc. Common Stock (MOBI)vs › | $305.56M | N/A | -0.02 | -0.02 | -0.02 |
| Benitec Biopharma Inc. (BNTC)vs › | $301.12M | -0.98 | -1.02 | -4.71 | -10.90 |
| Relmada Therapeutics, Inc. (RLMD)vs › | $349.28M | -0.92 | -2.05 | -3.17 | -3.94 |
Trailing EPS (TTM)
$-1.45
Forward EPS (Est.)
N/A
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -1.74 |
| 2024-12-31 | -2.39 |
| 2023-12-31 | -1.40 |
| 2022-12-31 | -1.07 |
| 2021-12-31 | -1.03 |
| 2021-06-30 | -1.17 |
| 2020-06-30 | -2.07 |
| 2019-06-30 | -1.12 |
| 2018-06-30 | -1.85 |
| 2017-06-30 | -1.73 |
| 2016-06-30 | -2.06 |
| 2015-06-30 | -2.26 |
| 2014-06-30 | -1.58 |
| 2013-06-30 | -2.66 |
| 2012-06-30 | -3.21 |
| 2011-06-30 | -1.13 |
| 2010-06-30 | -3.92 |
| 2009-06-30 | -3.78 |
| 2008-06-30 | -16.48 |
| 2007-06-30 | -3.24 |
| 2006-06-30 | -3.45 |
| 2005-06-30 | -0.18 |
| 2004-06-30 | -3.12 |
| 2002-12-31 | -2.02 |
| 2001-12-31 | -0.52 |
| 2000-12-31 | -0.78 |
| 1999-12-31 | -1.33 |
| 1998-12-31 | -2.25 |
| 1997-12-31 | -43.49 |
| 1996-12-31 | 4.13 |
